Abstract
We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2-positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images.
| Language | English |
|---|---|
| Pages | e96-e97 |
| Journal | Clinical Nuclear Medicine |
| Volume | 44 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2019 |
Cite this
18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases. / Cuppari, Lea; Reccia, Pasquale; Burei, Marta; Cervino, Anna Rita; Evangelista, Laura.
In: Clinical Nuclear Medicine, Vol. 44, No. 2, 02.2019, p. e96-e97.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - 18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases
AU - Cuppari, Lea
AU - Reccia, Pasquale
AU - Burei, Marta
AU - Cervino, Anna Rita
AU - Evangelista, Laura
PY - 2019/2
Y1 - 2019/2
N2 - We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2-positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images.
AB - We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2-positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images.
U2 - 10.1097/RLU.0000000000002407
DO - 10.1097/RLU.0000000000002407
M3 - Article
VL - 44
SP - e96-e97
JO - Clinical Nuclear Medicine
T2 - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
SN - 0363-9762
IS - 2
ER -